Skip to content
iasusa cover art

All Episodes

iasusa — 500 episodes · page 1 of 5

#
Title
1

(September 3, 2026) IAS-USA Dialogue Series: Emerging Infections and Health Threats

2

(June 9, 2026) IAS-USA Dialogue Series: Emerging Infections and Health Threats

3

1. Welcome and Introduction

4

2. Data to Decisions: The ART of Initial ART

5

5. Challenging Cases in Advanced HIV: Managing Opportunistic Infections and New Guidance on ART

6

6. Closing Remarks

7

3. Hepatitis B Dilemmas: Navigating HBV Risk in the Tenofovir-Sparing ART Era

8

4. Managing ARV Experienced Patients: I'd Rather Switch Than Fight!

9

(March 26, 2026) IAS-USA Dialogue Series: Emerging Infections and Health Threats

10

(HIV 2026 ATL) Key CROI 2026 Updates by Colleen F. Kelley, MD, MPH

11

(HIV 2026 ATL) STI Updates Current Trends in Treatment and Prevention by Jason E. Zucker, MD

12

(HIV 2026 ATL) Brain Health in Older Adults With HIV by Meredith Greene, MD

13

(HIV 2026 ATL) PrEP Updates New Long-Acting Injectables, Management Challenges, and Diagnostic Testing Dilemmas by ment Challenges, and Diagnostic Testing Dilemmas by Hyman Scott, MD, MPH

14

(HIV 2026 ATL) Cases in HIV Medicine Putting it all Together by Michael S. Saag, MD

15

(HIV 2026 ATL) Investigational Antiretroviral Drugs Injectables and Beyond by Rajesh T. Gandhi, MD

16

(HIV 2026 ATL) David Letterman as a Dermatologist Top 10 Skin Lesions You Should Know by Toby A. Maurer, MD

17

4. Updates on the Evolving Landscape of HIV Management in Pregnancy and Postpartum

18

9. SUDs in HIV Care: MOUD, Emerging Therapies, and PrEP in the Context of Stimulant Use

19

1. Welcome and Introductions

20

5. Key Updates From CROI 2026

21

7. Evolving Diabetes Care in PWH: Screening, Treatment, and the Rise of GLP-1 RA Therapies

22

6. Cases in the Clinic 2026: From Ragtime to Two Strangers

23

10. Immunizations for PWH: Efficacy, Safety, Evolving Recommendation

24

11. Closing Remarks

25

3. Optimizing Long-Acting Therapeutics in Practice: Real-World Considerations and Failure Management

26

8. Advances in HIV and STI Prevention: A 2026 Updat

27

2. Lifetime of Leadership Award Presented to Gerald H. Friedland, MD

28

RWCC Day 2: Rebecca Abelman - Hormones and Health The Menopausal Transition in Women With HIV

29

RWCC Day 2: Melanie Thompson - Screening for the Big Cs in HIV Care

30

RWWC Day 3: Henry Masur - HIV Associated OIs All Too Common Despite the Miraculous Advances in ART

31

RWWC Day 3: Welcome to Day 3

32

RWWC Day 3: Roy M. Gulick - Investigational Antiretroviral Drugs and Formulations

33

RWWC Day 3: Closing Remarks

34

RWWC Day 3: Sandra A Springer - Mastering the Clinical Triple Threat

35

RWCC Day 2: Caryn Morse - Aging With HIV Focus on Cognitive Impairment and Frailty

36

RWCC Day 2: Todd Brown - Metabolic Update 2025 Diabetes and CKM Syndrome

37

RWCC Day 1: Heather Hauck - HRSA Ryan White HIVAIDS Program Updates

38

RWCC Day 2: Michael Saag - Interactive ART Cases From the Clinic(ians) Case-Based Panel Discussion

39

RWCC Day 1: Khalil Ghanem - Preventing and Managing Syphilis in 2026

40

RWCC Day 1: Welcome and Introduction

41

RWCC Day 2: Roger Bedimo -No Mo FOMO

42

RWCC Day 2: Michael Saag - Welcome to Day 2

43

RWCC Day 1: Katharine J Bar - Update on the Cure From In Between Days to Just Like Heaven

44

RWWC Day 3: Christine M. Durand - HIV and Transplantation Practice and Possibilities

45

RWCC Day 2 Priscilla Y Hsue - 2025 Update on HIV and Cardiovascular Disease Lipids, Inflammation, and More

46

RWCC Day 1: Hyman Scott - Case-Based Approaches to Pre- and Postexposure Prophylaxis

47

“In Case You Missed It”: New Developments in HIV Prevention and Treatment

48

Closing Remarks

49

What Would You Do? Challenging Cases in HIV Management: Case-Based Panel Discussion

50

From DoxyPEP to Antimicrobial Resistance: The Changing Face of STIs

51

Be Prepared With PEP: Emergency Management of HIV, HBV, and HCV Exposures

52

Welcome and Introduction

53

HIV Vaccines in 2026 and Beyond: Promise and Persistence

54

Aging With HIV: How Not to Go Gently Into That Good Night

55

The Science of Aging: Epigenetics and Other Hallmarks of Aging

56

Immunization for Aging Adults With HIV: What’s New for the Old

57

Aging in the Context of HIV and Cancer: What Does “Age” Actually Mean?

58

Welcome and Introductions

59

Closing Remarks

60

HIV, Aging, and the Brain: A Practical Approach

61

From Fierce to Frail: Assessing Aging With HIV

62

Just Do It: Overcoming Clinical Inertia to Improve Heart Health

63

Update on the Cure: From In Between Days to Just Like Heaven

64

Closing Remarks

65

Beyond the Horizon: HIV Treatments in the Making

66

In Case You Missed It: Recent Changes in Guidelines, New Publications, & Updates

67

Aging with HIV: Optimizing Care for Older Adults

68

Welcome and Introduction

69

A Focused Update on Immunizations in People with HIV

70

Controversies in HIV Management: Case-Based Discussion

71

From Data to Action: Advances and Evolving Strategies in HIV and STI Prevention

72

(December 5, 2025) IAS-USA Dialogue Series: Emerging Infections and Health Threats

73

(August 13, 2025) Latest Update on Urgent Virus Outbreaks: Summer 2025

74

Chlamydia Management Updates: Advances and Vaccines Developments for STI Prevention

75

Latest Guidelines for Screening and Treatment for Human Papillomavirus and Anal Cancer

76

Welcome and Introduction

77

Preexposure Prophylaxis for HIV Infection: PrEP-Aring for The Next Decade

78

Preventing and Managing Syphilis in 2025

79

Updates on Hepatitis B Coinfection: Challenging Serology and Treatment Approaches

80

Drug-Resistant Gonorrhea: Epidemiology, Management, and Future Treatment

81

Closing Remarks

82

(May 13, 2025) Latest Update on Urgent Virus Outbreaks: Spring 2025

83

Ulcerative Sexually Transmitted Infections: Syphilis, Herpes Simplex Virus, Mpox, and Others

84

Updates on HIV Primary Care

85

Key Updates From CROI 2025

86

Year 13 of the Modern PrEP Era: A Spoon (Not a Fork) in the Road?

87

Weight Management and GLP-1 Receptor Agonists for People With HIV: Insights and Strategies

88

Interactive ART Cases From the Clinic(ians): Case-Based Panel Discussion

89

A Tough Nut to Crack? Update on Hepatitis B Cure

90

Next-Generation STI Prevention: DoxyPEP, CDC Guidelines, and the Gonorrhea Vaccine Debate

91

Treatment & Prevention of Syphilis in People With HIV, Addressing the Congenital Syphilis Epidemic

92

Anal Cancer Screening: Implementing Guidelines in the Real World

93

Challenging Cases in Antiretroviral Therapy and Panel Discussion

94

Gender-Affirming Hormone Initiation and Antiretroviral Therapy Considerations

95

PrEP Update: Long-Acting Agents and PrEP During Pregnancy

96

Update on HIV Primary Care: New Data, New Guidelines

97

Closing Remarks

98

CROI 2025 Insights To Treat, Per Chance to Cure HIV

99

Welcome and Introduction

100

(January 15, 2025) Latest Update on Urgent Virus Outbreaks: Winter 2025